ATE470856T1 - Gleichzeitigen flusszytometrischer messungen von die inhibition der zellproliferation und der toxizität - Google Patents

Gleichzeitigen flusszytometrischer messungen von die inhibition der zellproliferation und der toxizität

Info

Publication number
ATE470856T1
ATE470856T1 AT04005789T AT04005789T ATE470856T1 AT E470856 T1 ATE470856 T1 AT E470856T1 AT 04005789 T AT04005789 T AT 04005789T AT 04005789 T AT04005789 T AT 04005789T AT E470856 T1 ATE470856 T1 AT E470856T1
Authority
AT
Austria
Prior art keywords
toxicity
cell proliferation
inhibition
flow cytometric
simultaneous flow
Prior art date
Application number
AT04005789T
Other languages
English (en)
Inventor
Bernhard Goller
Manfred Kubbies
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE470856T1 publication Critical patent/ATE470856T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04005789T 2003-03-12 2004-03-11 Gleichzeitigen flusszytometrischer messungen von die inhibition der zellproliferation und der toxizität ATE470856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03005335 2003-03-12

Publications (1)

Publication Number Publication Date
ATE470856T1 true ATE470856T1 (de) 2010-06-15

Family

ID=32946848

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04005789T ATE470856T1 (de) 2003-03-12 2004-03-11 Gleichzeitigen flusszytometrischer messungen von die inhibition der zellproliferation und der toxizität

Country Status (7)

Country Link
US (1) US7202081B2 (de)
JP (1) JP2004337152A (de)
CN (1) CN100439919C (de)
AT (1) ATE470856T1 (de)
CA (1) CA2456534A1 (de)
DE (1) DE602004027567D1 (de)
ES (1) ES2344943T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101017168B (zh) * 2007-02-15 2012-08-29 广州万孚生物技术股份有限公司 荧光胶乳定量层析试纸条及其制备方法
CN101481651B (zh) * 2009-02-05 2011-09-21 上海纳米技术及应用国家工程研究中心有限公司 金属纳米材料毒性检测板及其检测方法
GB0911060D0 (en) 2009-06-26 2009-08-12 Ge Healthcare Uk Ltd Methods for predicting the toxicity of a chemical
JP2011092104A (ja) * 2009-10-30 2011-05-12 Hitachi Engineering & Services Co Ltd 微生物などの検査方法及び検査装置
CN103267752B (zh) * 2013-05-31 2015-04-08 北京大学 测定胰岛中a细胞与b细胞数目比例的方法
CN104807788B (zh) * 2014-12-18 2018-09-14 中山大学 一种用于监测血管重构现象的方法与试剂盒
CN106053405B (zh) * 2016-05-10 2018-10-02 东南大学 一种基于单分子定位法的超分辨光学成像方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US643378A (en) * 1899-10-30 1900-02-13 Charles C Jordan Washboiler.
CN1180108A (zh) * 1997-10-08 1998-04-29 陈学清 细胞增殖检测试剂盒(酸性磷酸酶法)

Also Published As

Publication number Publication date
DE602004027567D1 (de) 2010-07-22
US20040180390A1 (en) 2004-09-16
CN100439919C (zh) 2008-12-03
JP2004337152A (ja) 2004-12-02
ES2344943T3 (es) 2010-09-10
CN1530643A (zh) 2004-09-22
CA2456534A1 (en) 2004-09-12
US7202081B2 (en) 2007-04-10

Similar Documents

Publication Publication Date Title
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
EA199900162A1 (ru) Ингибиторы клеточной адгезии
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
ATE437370T1 (de) Pharmakodynamische tests mit durchflusszytometrie
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DE60124975D1 (de) Automatischer apparat zum messen von wassertoxizität
ATE470856T1 (de) Gleichzeitigen flusszytometrischer messungen von die inhibition der zellproliferation und der toxizität
ECSP045466A (es) Inhibidores de la peptido-desformilasa
ATE507209T1 (de) Referenzstandard zur charakterisierung von rosuvastatin
DeTemple et al. Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes
MXPA03011898A (es) Ensayo de seleccion in vitro para ?- secretasa.
WO2003080649A3 (en) Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE425962T1 (de) Peptid-deformylase-hemmer
DK1185873T3 (da) Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet
DE60327710D1 (de) Modifizierte zytokine für krebs therapie
SG144920A1 (en) Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide
DE60225168D1 (de) Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür
MX2010004097A (es) Complejos de los dominios de trpc y sestd1 y metodos y usos que implican los mismos.
ATE548037T1 (de) Peptid-deformylase-hemmer
DE60207833D1 (de) Peptiddeformylase-hemmer
EP1801231A4 (de) Verfahren zum screening des baff-suppressors oder -inhibitors
IS7441A (is) Peptíðdeformýlasatálmar
ATE531690T1 (de) Inhibitoren von peptiddeformylase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties